Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Peptonic Medical AB granted patent in Europe for relief of provoked vulvodynia in women. Product ready for launch.

Peptonic Medical AB (publ) ("Peptonic") announces that the European Patent Office ("EPO") has granted a patent for the relief of provoked vulvodynia (previously referred to as vestibulitis), effective until April 2041. VagiVital Intimate Calming Gel, the company's proprietary product designed to alleviate the discomfort associated with vulvodynia, will be launched later this year. The product will also be introduced to existing and new international partners for broad distribution.VagiVital Intimate Calming Gel provides immediate soothing and moisturizing effects for vulvodynia and relieves

Change in number of SSAB shares and votes

As of May 31, 2024, the number of SSAB shares totals 996,617,667, of which 295,966,330 are Class A shares and 700,651,337 are Class B shares. The total number of votes in the company is 366,031,463.7, of which Class A shares convey 295,966,330 votes, and Class B shares 70,065,133.7 votes.The decrease in the number of shares is due to SSAB’s cancellation of 33,217,659 shares (of which 8,216,940 are Class A shares and 25,000,719 are Class B shares) in accordance with the resolution of the Annual General Meeting on April 24, 2024. The share capital of SEK 9,062,550,868.80 is unchanged since

Lindab acquires Danish ventilation company Venti

Lindab complements its current operations in Denmark with the acquisition of Venti A/S. The acquisition gives Lindab better geographical coverage and increased production of ventilation ducts.Venti manufactures circular and rectangular ventilation ducts and is a distributor of ventilation products such as silencers, fittings, and a wide range of technical products for air diffusion. Sales and distribution take place in two locations in Denmark, outside Aarhus and Copenhagen. Venti does not sell Lindab products at present. "Venti is a customer-focused company with solid ventilation

Norse Atlantic Airways Celebrates Inaugural Nonstop Flight from Athens to New York JFK

Norse Atlantic Airways today celebrated is the commencement of its inaugural nonstop flights between Athens and New York JFK.Operated by the state-of-the-art Boeing 787 Dreamliner, passengers can now enjoy the convenience of a direct and affordable flight between these two vibrant cities. From the historical wonders of Athens to the iconic landmarks of New York, passengers will have the opportunity to explore the rich cultural heritage and diverse attractions each city has to offer. Flights operate up to five times a week during the summer season with fares starting from €239 one way in

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 122 – 31 MAY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Reminder: Last day to subscribe in Jumpgate AB’s ongoing rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN JUMPGATE AB. SEE ALSO IN THE SECTION "IMPORTANT INFORMATION" BELOW.Wednesday, June 5, 2024, is the last day to subscribe for shares in Jumpgate AB's ("Jumpgate" or the "Company") rights issue of shares amounting to approximately SEK 28.6

Unaudited Interim Results

Capital for Colleagues plc / EPIC: CFCP / Market: AQSE / Sector: Financials   31 May 2024 CAPITAL FOR COLLEAGUES PLC (‘Capital for Colleagues’, ‘C4C’ or the ‘Company’)     Unaudited Interim Results for the six months ended 29 February 2024   Capital for Colleagues, the investment vehicle focused on opportunities in the Employee Owned Business (‘EOB’) sector, is pleased to announce its unaudited interim results for the six months ended 29 February 2024.   Financial Highlights · Revenues of £0.421m (2023: £0.259m), comprising interest receivable, dividends

C-Green annual general meeting on June 28, 2024

     Shareholders are welcome to C-Green's annual general meeting on June 28, 2024 in Solna. Shareholders who wish to participate must be entered in the share register kept by Euroclear Sweden AB by June 19, 2024, and may attend the meeting in person or through an authorized representative. The notice and other documents related to the meeting are available on C-Green's website: www.c-green.se/investors. (in Swedish)

Qred wins Nordic Scaleup Award 2024

This week Qred was honored with the Nordic Scaleup Award 2024. The award recognizes Qred’s growth and impact as the newest small business bank  in the Nordic region, where they have distinguished themselves among 82 nominated companies. Stockholm, May 31, 2024 — This week Qred, the newest bank for small businesses, received the prestigious Nordic Scaleup Award 2024. The award, which gathered some of the most successful growth companies in the Nordics, had a total of 82 nominated companies, of which six reached the final. Among the finalists were three Finnish, two Swedish, and

The subscription period in Smoltek’s rights issue of shares starts today

This press release is an English version of the previously published Swedish version, which has interpretive precedence. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES.  Smoltek Nanotech Holding AB (publ) (“Smoltek” or the “Company”)

Catena publishes an updated MTN prospectus

In 2021, Catena established an MTN program (MediumTerm Notes) for issuance purposes in the Nordic capital market with a framework of SEK 5 billion. Catena has now updated the prospectus for the MTN program.31 May 2024, 9.20 a.m. CEST The updated prospectus has been approved and registered by the Swedish Financial Supervisory Authority (SFSA/Finansinspektionen) today, 31 May 2024. The prospectus is available on Catena’s website www.catena.se and on SFSA’s website www.fi.se. The prospectus has been updated to allow for continued issuance of bonds under the MTN program. The prospectus is

Saab receives large order for defence equipment

Saab has today received an order from the Government of a Western country for a number of defence systems and equipment. The order value is approximately SEK 7.7 billion with deliveries planned 2027-2028.The order includes systems and equipment from Saab’s business areas Dynamics and Surveillance. Due to the nature of the industry, circumstances concerning the customer and national security interests, no further information regarding these orders or the customer will be provided. Contact Mattias RådströmHead of Media Relations+46 (0)734 180 018presscentre@saabgroup.com

ABAX Group AS: Publication of Q1 report January – March 2024

Larvik, Norway | ABAX Group AS, a leading provider of telematics and smart mobility services, today announced its financial results for the first quarter of 2024, showcasing continued growth and strategic advancements. The Q1 report is available on the company website at: https://www.abax.comQ1 2024 Financial Highlights · Revenue: ABAX Group AS achieved a revenue of 204,4 MNOK for Q1 2024, reflecting a 6% growth year-over-year from 192,8 MNOK in Q1 2023. · Revenue outside of Sweden: The company achieved a growth of 12 % year-over-year outside of Sweden, which remains impacted by

Read original

Converting class A shares

During the month of May, the number of shares in Addtech AB has changed due to shareholders request for conversion of 21,360 class A shares to corresponding number of class B shares. After the conversion the total number of class A shares is 12,864,384 and class B shares 259,929,600. The number of shares and the number of votes in Addtech AB are shown in the table below:  Number of Number of Number of Number of class A shares class B shares votes sharesBefore conversion 12,885,744 259,908,240 388,765,680

Change in the number of votes in Bravida Holding AB

Bravida Holding AB (BRAV) today announces a change in the number of votes in the company. This is due to the conversion of some class C shares to ordinary shares, which will be assigned to participants in incentive programmes.At Bravida’s 2021 Annual General Meeting, a resolution was passed to implement a long-term incentive programme for senior executives and other key personnel in the Bravida Group (“LTIP 2021”). Following publication of the interim report for the period 1 January to 31 March 2024, allocation of shares has been made to a total of 152 senior executives and other key

Save the date - MilDef organizes Capital Markets Day on 17 September 2024

MilDef invites to a Capital Markets Day for investors, analysts and media, on September 17. The program starts at 9.00 am at At Six in Stockholm and ends with lunch at 12 noon.Representatives from MilDef's Corporate Management team, headed by President and CEO Daniel Ljunggren, will present MilDef's development and strategies for continued growth. During the program, management will describe MilDef's position in the defense technology domain, MilDefs product portfolio, sales strategy, industry trends and the financial position. The presentations will be held in English. The program

Sanolium interim report Q1 Jan-Mar 2024

Today Sanolium releases the interim report for the first quarter this year“We have continued developing the company in line with our strategic direction during the first quarter 2024. Im proud to see such progress among our ongoing projects as well as the trust from new customers as we continue on the journey towards a healthier tomorrow,” says Rami Avidan, CEO of Cambio A number of important steps has been taken during Q1: · Frame agreement with Karolinska Institute · Continued preparations for the go live with Sussa, one of the largest IT healthcare projects in Europe ·

Accenture to provide consulting services for SSAB’s transformation to fossil-free mini-mills

SSAB and Accenture have signed a long-term framework agreement to provide consulting and technology services to support SSAB’s transformation to fossil-free steel. Accenture will lead the design and implementation of the business technology platform covering multiple areas and processes of the new mini-mills, starting with the first implementation at the mini-mill in Luleå, Sweden. From left to right: Abhishek Sinha (Accenture), Fredrik Engdar (Accenture), Niko Korte (SSAB), Veli-Pekka Mäkinen (BDO), Tuomo Kuokkanen (Accenture). SSAB has taken a policy decision to fundamentally

Notice to the annual general meeting of Beyond Frames Entertainment AB (publ)

The shareholders in Beyond Frames Entertainment AB (publ) (the "Company"), reg. no. 559058-8322, are invited to the annual general meeting at the Company's premises at Bondegatan 21, 116 32 in Stockholm on June 28, 2024 at 13.00.   Right to participate and registration The right to participate in the general meeting has the shareholder who is partly entered in the share register maintained by Euroclear Sweden AB for the company on 19 June 2024, and has notified the company of their intention to participate so that the notification reaches the company no later than 21 June 2024.

Nel ASA: Cavendish Hydrogen ASA applies for admission to trading on the Oslo Stock Exchange – invitation to investor meetings

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. (May 31, 2024 - Oslo, Norway) Reference is made to the stock exchange announcements by Nel ASA (Nel, OSE: NEL) on February 28, and May 15, 2024 regarding the potential spin-off of Nel's Fueling division into a separate company, Cavendish Hydrogen ASA ("Cavendish"), and listing of Cavendish' shares on the Oslo Stock Exchange.

Changes in executive management in Movinn (DK)

Current Head of Operations, Jakob Thye, is promoted to Chief Operating Officer (COO) in Movinn Denmark from 1 june 2024.Company Announcement nr. 56 - 202431 May 2024 08.45 CET. This company announcement contains inside information.  Copenhagen, Denmark - Movinn appoints Jakob Thye as Chief Operating Officer (COO) in Movinn (Denmark) on 1 June 2024. Jakob is currently Head of Operations and is being internally promoted to the executive management team. Existing team members in the service department will be taking over some of Jakobs task, but the Company is not bringing in additional

The subscription period in NextCell’s rights issue commences today

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, CANADA, HONG KONG, BELARUS, RUSSIA OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLISHING OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW. SEE SECTION ”IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.  Today, 31 May 2024, the subscription period in NextCell Pharma AB (publ)’

Biosergen publishes interim report for first quarter 2024

Friday, May 31, 2024: Biosergen AB (“Biosergen” or the “Company”) hereby publishes the interim report for the first quarter 2024. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q1 2024 2024 2023 2023TSEK Jan-Mar Jan-Mar Jan-Dec Profit/loss Other income 693 5.315 9.378Profit/loss before depreciation (EBITDA -6.798 -5.029 -27.265Operating

There are no items matching the current filter
There are no more items matching the current filter
Back to top